We’re pleased to share that members of the Dehns Biotechnology Group will be attending OBN’s BioSeed 2025 on Monday, 9 June. Senior Partner Elizabeth Jones, Head of the Biotechnology Group Hanna Dzieglewska, and Patent Attorney Rosie Lawrence will be representing Dehns at this exciting event, where they will be exhibiting and engaging with innovators across the life sciences sector.

BioSeed is OBN’s fast-paced sell-out pitching and investment event where early-stage R&D companies seeking seed funding pitch to a packed room of active life sciences investors. Find out more at www.bioseed.co.uk.

With extensive experience in supporting early-stage life science companies, our team is well-placed to provide strategic IP advice to help protect innovation, attract investment, and support long-term growth. We look forward to connecting with emerging ventures and contributing to their journey from discovery to commercial success.

Click here if you would like to arrange a meeting with one of our team >